Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?

Faik G. Uzunoglu, Christoph Springfeld, Teresa Peccerella, Thomas Hank, Martin Loos, Christoph W. Michalski, Thilo Hackert, John P. Neoptolemos